Navigation Links
Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
Date:7/22/2009

PHILADELPHIA and LONDON, July 22 /PRNewswire/ -- The 2009 edition of the trusted and often cited compendium of pharmaceutical research and development statistics, the CMR International Pharmaceutical R&D Factbook, is now available. This year's Factbook offers extended content including patent information and emerging trends in worldwide pharmaceutical R&D.

"The R&D Factbook provides the data that R&D companies need to make informed decisions," said Dr. Jane Sharples, General Manager of CMR International. "With this publication, R&D companies can gain insights into industry dynamics and trends, determine how they perform against the market as a whole and gauge their productivity in relation to their peers and competitors. Companies can also see the consequences of adopting different R&D strategies. In short, they have accurate, independent and validated information on which to base business decisions."

Highlights of the 2009 edition include:

  • The number of new molecular entities (NME) launched onto the global market failed to improve on 2008's 20-year low. Actual development times for new molecular entities are slowly increasing to 14 years, though major pharmaceutical companies (those that spent more than $2 billion on R&D in 2008) take on average slightly more than 11 years.
  • Anti-cancer therapy is the most common area for new patent filing on emerging targets.
  • India leads the way in the recent trend towards new molecular entity research by generic specialty companies.

The Centre for Medicines Research International Ltd (CMR International), a Thomson Reuters business, yearly publishes the Factbook. This is an up-to-date business planning tool for decision makers in the pharmaceutical industry, including R&D, corporate finance, business strategy, marketing pla
'/>"/>

SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
2. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
3. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
4. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
5. Thomson Scientific Begins Expansion of Web of Science
6. Thomson Reuters Launches New Biomarkers Solution
7. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
8. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
9. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
10. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
11. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. ... a randomized Phase 2B study of AEG35156, a target...for multiple oncology indications. ,, The study... of the X-Linked Inhibitor of Apoptosis (XIAP) Ant...e Cytarabine and Idarubicin in AML Following Failu...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies Form I...oordinate Best Practices in Risk Reduction ,Five...e Gene Synthesis Capacity , ...rsquo;s leading gene synthesis companies today ann...eening protocol to promote biosecurity in the gene...
(Date:11/19/2009)...VIENNA, Austria, November 19 AFFiR...n one product candidate at an unexpectedly early,s... planned to enter into,Phase II clinical trial ear...ly follows the completion of two Phase I trials wi... its fast decision on the first interim,analysis o...
(Date:11/18/2009)...National Institute of Standards and Technology (NI...ive method for detecting and measuring elusive haz...sible spoilage in food or pesticides distributed i...ore sensitive than conventional techniques for det...ike water molecules, having distinct electrically ...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2
...SAN DIEGO, Oct. 31 Arena Pharmaceuticals,Inc. (Na...scheduled to,present at the Acumen BioFin Rodman &...ber 6, 2007 at 12:20 p.m. Eastern Time (9:20 a.m.,...York City. Robert E.,Hoffman, Arena,s Vice Preside...led to provide a corporate overview of the company...
..., This release is also available in German . ,...teps exhibited by the molecules, which start as ra...the evolution of life. The organization is activat...ules. During assembly, molecules exhibit active se... room for others which fit properly. The molecular...
..., WEST LAFAYETTE, Ind. - Researchers at Purdue Uni...eloped tiny wireless sensors resilient enough to s...detect when critical bearings are close to failing...mple of an emerging technology known as "micro ele...es that combine electronic and mechanical componen...
Other Biology Technology:Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Evolution in the nanoworld 2Evolution in the nanoworld 3Purdue creating wireless sensors to monitor bearings in jet engines 2Purdue creating wireless sensors to monitor bearings in jet engines 3
(Date:11/20/2009)...scientific and technological frontiers. The Nation...t that totals nearly $4.3 million for the diverse ...merican Recovery and Reinvestment Act of 2009. , ...nvestigation of solar phenomena. Philip R. Goode, ...he capabilities of NJIT,s Big Bear Solar Observato...
(Date:11/20/2009)...heir abstracts to the World Congress on Osteoporos...ting devoted to all aspects of osteoporosis and os...ss will be held in Florence, Italy from May 5-8, 2...ed online at http://www.iofwco-ecceo10.org , ...OF and ESCEO are pleased to announce that seven sp...
(Date:11/20/2009)...rial gene into yeast, researchers from Delft Unive...ree improvements in bioethanol production from agr...ate and elimination of the major by-product glycer...cientific journal Applied and Environmental Micro... the yeast Saccharomyces cerevisiae from sugars ob...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Delft breakthrough in bioethanol production from agricultural waste 2MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 1MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 2MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 3China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 1China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 2China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 3K State program will give young professionals skills to protect water resources 10693 1
...ment shed new light on the health effects of expos... to the World Trade Center disaster on September 1...er Health Registry, show that 3.6% of the 25,000 r...y report developing asthma after working at the si...xpected for the adult population during such a tim...
...d their collaborators will make it much easier to ...teomics data. The papers are published in Nature B...antity of available biological information and the...tency in the information held in these databases i...mparison of their contents. As Europes main provid...
...ld but so too are cheats mutants that do not cont...benefits of others cooperative efforts. In evoluti...cooperation persists despite the threat of cheat t...gists at the Universities of Edinburgh and Oxford ...strate their own downfall. , In the study, report...
Other Biology News:Survey finds elevated rates of new asthma among WTC rescue and recovery workers 2Survey finds elevated rates of new asthma among WTC rescue and recovery workers 3Minimum information standards -- all for 1 and 1 for all 2Minimum information standards -- all for 1 and 1 for all 3Social parasites of the smaller kind 2
Molecular Immunology from Promega
Peptide Antibody from Proteintech Group, Inc.
..., 1. Modular system for large format and medium th...t or precast gels (26 x 20 cm) simultaneously.Use ...to-use 1.0-mm or 1.5-mm pre-assembled hinged gel c...unloading.Built-in ceramic heat exchanger and buff...
ELF® 97 Immunohistochemistry Kit from Molecular Probes (Invitrogen)
Biology Products: